Thursday, September 24, 2020
In a time of universal deceit, telling the truth is a revolutionary act.

F.D.A. Revises Its Letter for Nonapproval of Drugs

Drug makers whose products are not ready for approval in the U.S. will soon get the word from regulators in a new format intended partly to avoid scaring investors.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Drug makers whose products are not ready for approval in the U.S. will soon get the word from regulators in a new format intended partly to avoid scaring investors.

%d bloggers like this: